Fil LTD Profound Medical Corp. Transaction History

Fil LTD

$116 Billion
Q3 2025

A detailed history of Fil LTD transactions in Profound Medical Corp. stock. As of the latest transaction made, Fil LTD holds 1,885,000 shares of PROF stock, worth $12.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,885,000

Previous 1,885,000 -0.0%

Holding current value

$12.6 Million

Previous $11.1 Million 14.23%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$4.04 - $6.86 $282,800 - $480,200	70,000 Added 3.86%	1,885,000 $11.1 Million
Q1 2025 May 12, 2025	BUY	$5.81 - $7.9 $116,199 - $158,000	20,000 Added 1.11%	1,815,000 $10.6 Million
Q4 2024 Feb 13, 2025	BUY	$6.98 - $8.96 $1.81 Million - $2.33 Million	260,000 Added 16.94%	1,795,000 $13.5 Million
Q3 2024 Nov 13, 2024	BUY	$7.47 - $11.18 $224,100 - $335,400	30,000 Added 1.99%	1,535,000 $12.2 Million
Q2 2024 Aug 13, 2024	BUY	$7.25 - $9.07 $1.12 Million - $1.4 Million	154,365 Added 11.43%	1,505,000 $12.6 Million

Q1 2024 May 13, 2024	BUY	$7.3 - $9.46 $1.1 Million - $1.42 Million	150,000 Added 12.49%	1,350,635 $11.5 Million
Q2 2023 Aug 11, 2023	BUY	$9.27 - $14.88 $120,602 - $193,588	13,010 Added 1.1%	1,200,635 $15.6 Million
Q1 2023 May 11, 2023	SELL	$8.85 - $13.27 $336,742 - $504,923	-38,050 Reduced 3.1%	1,187,625 $11 Million
Q4 2022 Feb 13, 2023	BUY	$3.18 - $10.91 $382,522 - $1.31 Million	120,290 Added 10.88%	1,225,675 $13.3 Million
Q3 2022 Nov 10, 2022	BUY	$3.99 - $9.3 $59,850 - $139,500	15,000 Added 1.38%	1,105,385 $4.47 Million
Q2 2022 Aug 12, 2022	BUY	$6.34 - $9.53 $158,563 - $238,345	25,010 Added 2.35%	1,090,385 $7.96 Million
Q1 2022 May 13, 2022	BUY	$8.16 - $11.33 $326,400 - $453,200	40,000 Added 3.9%	1,065,375 $9.59 Million
Q4 2021 Feb 14, 2022	BUY	$10.38 - $15.2 $259,500 - $380,000	25,000 Added 2.5%	1,025,375 $11.6 Million
Q3 2021 Nov 15, 2021	BUY	$13.6 - $17.88 $1.7 Million - $2.24 Million	125,030 Added 14.28%	1,000,375 $14.6 Million
Q2 2021 Aug 13, 2021	BUY	$16.0 - $20.59 $800,160 - $1.03 Million	50,010 Added 6.06%	875,345 $14.3 Million
Q1 2021 May 14, 2021	SELL	$19.16 - $28.09 $3.83 Million - $5.62 Million	-200,025 Reduced 19.51%	825,335 $16.6 Million
Q4 2020 Feb 08, 2021	SELL	$16.4 - $22.9 $1.64 Million - $2.29 Million	-100,010 Reduced 8.89%	1,025,360 $21.1 Million
Q3 2020 Nov 13, 2020	BUY	$14.05 - $18.13 $3.23 Million - $4.17 Million	229,950 Added 25.68%	1,125,370 $19.8 Million
Q2 2020 Aug 13, 2020	BUY	$9.41 - $16.94 $282,252 - $508,115	29,995 Added 3.47%	895,420 $15.2 Million
Q1 2020 May 14, 2020	SELL	$6.88 - $19.7 $758,176 - $2.17 Million	-110,200 Reduced 11.3%	865,425 $8.33 Million
Q4 2019 Feb 07, 2020	BUY	$6.4 - $11.95 $6.24 Million - $11.7 Million	975,625 New	975,625 $11.1 Million

Others Institutions Holding PROF

# of Institutions

Shares Held

11.2M

Call Options Held

Put Options Held

View Full List

About Profound Medical Corp.

Ticker PROF
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,851,300
Market Cap $139M
Description
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...

More about PROF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fil LTD with notifications on news.

Account